CYBERDYNE Inc. manufactures and sells medical devices in Japan. More Details
Flawless balance sheet with high growth potential.
Share Price & News
How has CYBERDYNE's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 8C4's share price has been volatile over the past 3 months.
7 Day Return
DE Medical Equipment
1 Year Return
DE Medical Equipment
Return vs Industry: 8C4 underperformed the German Medical Equipment industry which returned 23.7% over the past year.
Return vs Market: 8C4 underperformed the German Market which returned 1.7% over the past year.
Price Volatility Vs. Market
How volatile is CYBERDYNE's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is CYBERDYNE undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 8C4's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 8C4's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 8C4 is unprofitable, so we can't compare its PE Ratio to the DE Medical Equipment industry average.
PE vs Market: 8C4 is unprofitable, so we can't compare its PE Ratio to the German market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 8C4's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 8C4 is good value based on its PB Ratio (3.6x) compared to the DE Medical Equipment industry average (4.4x).
How is CYBERDYNE forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8C4 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Earnings vs Market: 8C4 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 8C4's is expected to become profitable in the next 3 years.
Revenue vs Market: 8C4's revenue (32% per year) is forecast to grow faster than the German market (6.1% per year).
High Growth Revenue: 8C4's revenue (32% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 8C4's Return on Equity is forecast to be low in 3 years time (1%).
How has CYBERDYNE performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 8C4 is currently unprofitable.
Growing Profit Margin: 8C4 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 8C4 is unprofitable, but has reduced losses over the past 5 years at a rate of 19.5% per year.
Accelerating Growth: Unable to compare 8C4's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 8C4 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (14.8%).
Return on Equity
High ROE: 8C4 has a negative Return on Equity (-1%), as it is currently unprofitable.
How is CYBERDYNE's financial position?
Financial Position Analysis
Short Term Liabilities: 8C4's short term assets (¥28.8B) exceed its short term liabilities (¥518.0M).
Long Term Liabilities: 8C4's short term assets (¥28.8B) exceed its long term liabilities (¥2.8B).
Debt to Equity History and Analysis
Debt Level: 8C4's debt to equity ratio (0.2%) is considered satisfactory.
Reducing Debt: 8C4's debt to equity ratio has reduced from 72.3% to 0.2% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 8C4 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 8C4 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 32.5% each year
What is CYBERDYNE current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 8C4's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 8C4's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 8C4's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 8C4's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 8C4's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Yoshiyuki Sankai (62 yo)
Mr. Yoshiyuki Sankai has been the President and Chief Executive Officer of CYBERDYNE Inc. since February 2006 and also serves as its Chairman. Mr. Sankai established CYBERDYNE, Inc. in June 2004. He has be ...
|Chairman||14.67yrs||no data||5.04% |
|Team Leader of Information Strategy Team & Director||16.33yrs||no data||no data|
|Head of Corporate Unit & Director||11.67yrs||no data||0.028% |
|Outside Audit & Supervisory Board Member||13.33yrs||no data||no data|
|Independent Outside Director||5.33yrs||no data||no data|
|Independent Outside Director||7.33yrs||no data||0.028% |
|Outside Audit & Supervisory Board Member||9.33yrs||no data||no data|
|Director||16.33yrs||no data||0.0065% |
|Independent Outside Director||12.33yrs||no data||no data|
|Outside Audit & Supervisory Board Member (Full-Time)||9.33yrs||no data||no data|
Experienced Board: 8C4's board of directors are seasoned and experienced ( 11.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CYBERDYNE Inc.'s company bio, employee growth, exchange listings and data sources
- Name: CYBERDYNE Inc.
- Ticker: 8C4
- Exchange: DB
- Founded: 2004
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: JP¥160.707b
- Listing Market Cap: JP¥1.294b
- Shares outstanding: 215.14m
- Website: https://www.cyberdyne.jp
Number of Employees
- CYBERDYNE Inc.
- 2-2-1, Gakuen-Minami
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|7779||TSE (The Tokyo Stock Exchange)||Yes||Common Shares||JP||JPY||Mar 2014|
|8C4||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Mar 2014|
|CYBQ.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Mar 2014|
|CYBQ.Y||OTCPK (Pink Sheets LLC)||SPONSORED ADR||US||USD||Oct 2015|
CYBERDYNE Inc. manufactures and sells medical devices in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use for people who have disorders in the lower limb and leg weaknesses, as well as ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/21 20:31|
|End of Day Share Price||2020/10/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.